Efficacy of Probiotic ES1 for the Treatment of Non-Celiac Gluten Sensitivity

NCT02810301 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Exzell Pharma Inc.